Evidence map›Paper›PMID 42666392›Full record

ArticleGynecologic oncology reports2026

Prognostic value of the nutritional risk index and prognostic nutritional index for immunotherapy outcomes in cervical Cancer.

Julia Chalif, Molly Morton, Eric McLaughlin, Jessica Fulton, Jessica Sciuva, Ioana Marcu, Anna Gonzalez, Kristin L Bixel, David E Cohn, Casey M Cosgrove and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Julia ChalifDivision of Gynecologic Oncology; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, United States.
Molly MortonDivision of Gynecologic Oncology; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, United States.
Eric McLaughlinCenter for Biostatistics, The Ohio State University, Columbus, OH, United States.
Jessica FultonDivision of Gynecologic Oncology; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, United States.
Jessica SciuvaThe Ohio State University College of Medicine, Columbus, OH, United States.
Ioana MarcuThe Ohio State University, Division of Urogynecology, Department of Obstetrics and Gynecology, USA.
Anna GonzalezDivision of Gynecologic Oncology; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, United States.
Kristin L BixelDivision of Gynecologic Oncology; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, United States.
David E CohnDivision of Gynecologic Oncology; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, United States.
Casey M CosgroveDivision of Gynecologic Oncology; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, United States.
Larry J CopelandDivision of Gynecologic Oncology; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, United States.
Christa I NagelDivision of Gynecologic Oncology; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, United States.
Floor BackesDivision of Gynecologic Oncology; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, United States.
David O'MalleyDivision of Gynecologic Oncology; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, United States.
Laura ChambersDivision of Gynecologic Oncology; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, United States.

Funding

The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
Advanced Research Training in Immunology for Surgery Trainees (ARTIST)T32AI106704 · NIAID · OHIO STATE UNIVERSITY · PI GINNY L BUMGARDNER, Jon R Wisler · 2014 to 2026
$3.5M
NCATS NIH HHS UL1 TR001070NIAID NIH HHS T32 AI106704
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cervical CancerImmunonutritionImmunotherapyNutritionNutrition risk indexPrognostic nutritional index

Identifiers

PMID42666392
PMCPMC13522238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.